Tag Archives: outcomes

Belviq's Battle of the Bulge

Arena Pharmaceuticals’ and marketing partner Eisai’s Belviq – the first FDA-approved drug to treat obesity in over a decade – is making progress with payers and beefing up sales forces to target primary care physicians. DTC support began in September. Perhaps the most significant development in obesity of late is the recognition by payers – […]
Posted in Advertising, FDA, Global, healthcare, Market Access, Marketing, Patient Communication, People, pricing, Regulatory, Safety, Sales, Strategy | Also tagged , , , , , , , , , , , , , | Leave a comment

Why the Slow Take-up of Comparative Effectiveness Research? It's Time and Money, Says a New PCORI Survey

Earlier this week, the federal government’s Patient Centered Outcomes Research Institute (PCORI) unveiled a new survey, revealing that both patients and clinicians want in health research to focus on one thing: improving outcomes. A panel of healthcare providers discussed how findings will impact the structure and content of comparative effectiveness research (CER), advocating patient-centric dissemination […]
Posted in healthcare, Medical Education, Meetings, multimedia, Patient Communication, patient education, Strategy, Technology | Also tagged , , , , , , , | Leave a comment

On the Record: Colleen McHorney’s Next Step Agenda on Medication Adherence

PharmExec sat down with Colleen A. McHorney, PhD, former Senior Scientist at Merck’s U.S. Outcomes Research to review her long record of scientific research on adherence in advance of her retirement last month. McHorney highlights the cyclical nature of engagement on adherence programs, technology’s inherent inadequacies, the need to study the provider as well as […]
Posted in Patient Communication | Also tagged , , , , , | 2 Comments

PCORI Launches Clinical Research Network to Support Trials, Outcomes Research

The new National Patient-Centered Clinical Research Network funded by the Patient-Centered Outcomes Research Institute (PCORI) aims to provide patients and clinicians with useful information on treatment options and outcomes. By encouraging more comparative clinical effectiveness research (CER),  the program also has potential to support development of new drugs and devices, explained PCORI executive director Joe […]
Posted in FDA, healthcare | Also tagged , , , , , , , , , , , , , | Leave a comment
  • Categories

  • Meta